CClinicalTrials.gg
RecruitingNCT06417385Updated Feb 6, 2026

taVNS-Paired Breastfeeding to Improve Breastfeeding at Discharge

An interventional study of taVNS soterix device in Premature Birth, Breastfeeding, Exclusive and Feeding; Difficult, Newborn, sponsored by Medical University of South Carolina. Recruiting at 1 site in United States. Open to participants aged 35 Weeks and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-06.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
35 Weeks and older
Sex
All
01

Study summary

Investigators aim to improve the skills of premature or sick term infants in breastfeeding by boosting motor learning with transcutaneous vagus nerve stimulation. Investigators will recruit 10 premature, ≥ 35 weeks gestational age, or convalescing sick term infants admitted to the NICU at MUSC to participate in this study. Infants will receive taVNS treatments once a day with breastfeeding's for up to 14 days. Before each treatment, the researcher will determine how much electrical stimulation is needed for the infant to feel a slight tingle without discomfort, and during daily treatment paired with breastfeeding the infant will continue to receive this level of electrical stimulation, coinciding with latching and sucking, repeated over the duration of the feed. Investigators will collect information about the pre- and post-feed weights, the length of time for each feed, and observations of latch, suck, and swallow techniques by the infant from parents and the lactation consultant. Investigators will also evaluate parental satisfaction associated with their infant's ability to breastfeed after taVNS by providing parental satisfaction surveys at the beginning, after 1 and 2 weeks, and at 3 months after the end of the study to assess infants' progress in and maintenance of breastfeeding abilities.

If the pairing of breastfeeding with taVNS is able to result in improved outcomes of effective breastfeeding in infants in the neonatal intensive care units, this intervention could be further utilized by NICUs to increase the rate of premature and sick term infants who are successfully able to breastfeed at the time of discharge and maintain breast feeding longer after discharge. This would allow premature infants to acquire the many benefits of breastmilk as well as contribute towards the strengthening of the maternal-infant bond that breastfeeding has been shown to enhance.

02

Conditions studied

  • Premature Birth
  • Breastfeeding, Exclusive
  • Feeding; Difficult, Newborn
03

In context

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's planned enrollment of 10 is below the median of 84 across 1,691 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Weeks and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Infants ≥ 35 weeks post-menstrual age,
  • Clinically stable, without significant respiratory support,
  • Deemed safe to breastfeed by OT/SLP/lactation,
  • Maternal interest in breastfeeding,
  • Are not breastfeeding well despite the assistance of a lactation consultant.

Exclusion criteria

Exclusion Criteria:

  • Cardiomyopathy,
  • Unstable bradycardia,
  • Significant respiratory support,
  • Absent maternal interest in breastfeeding, or infant or mother with contraindications to breastfeeding such as infantile galactosemia,
  • Maternal HIV without adequate viral suppression,
  • Maternal illicit drug use.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    taVNS treatment group

    All 10 infants will receive active taVNS during breastfeeding sessions. There is no randomization or blinding involved.

    Device: taVNS soterix device

Interventions

  • DevicetaVNS soterix device

    Soterix is a custom modified, FDA-cleared electrical stimulator that meets the criteria of the FDA for investigational use. Neoleads will be placed in order to deliver electrical stimulation using microcurrent (\<2.5mA) with breastfeeding, on with sucking and swallowing and off with rest for 5 feeds per week for 2 weeks.

06

What researchers measure

Primary outcomes

  1. Adequate volume transfer during breastfeeding

    Measured by pre- and post-feed weights (grams)

    Time frame: 2 weeks

  2. Infant's ability to sustain breastfeeding for a length of time

    Average length of active feeding at the breast (minutes)

    Time frame: 2 weeks

  3. Targeted motor learning of skills involved in breastfeeding

    Demonstration of successful latch, suck, and swallow techniques by the infant per LATCH scoring (L= latch, A= audible swallowing, T= type of nipple (inverted, flat, everted after stimulation), C= Comfort of mother during feed, H= Hold/positioning of infant), scoring 0-10 (2 points per question) with 10 being the highest and optimal score.

    Time frame: 2 weeks

  4. Targeted motor learning of skills involved in breastfeeding

    Demonstration of successful latch, suck, and swallow techniques by the infant by study personnel descriptions (Only lactation consultants are trained to obtain LATCH scores, thus when no lactation consultant is present, study personnel will simply describe infant's demonstrated skills during the session without a specific measurement tool)

    Time frame: 2 weeks

Secondary outcomes

  1. Frequency of breastfeeding assessed by study specific survey

    Answers to related questions on taVNS-paired breastfeeding parental satisfaction survey

    Time frame: 2 months

  2. Parent satisfaction with infant's ability to breastfeed assessed by study specific survey

    Answers to related questions on taVNS-paired breastfeeding parental satisfaction survey

    Time frame: 2 months

  3. Level of connectedness and social-emotional bond felt by mother towards infant assessed by study specific survey

    Answers to related questions on taVNS-paired breastfeeding parental satisfaction survey

    Time frame: 2 months

07

Study locations

1 of 1 sites recruiting
  • Medical University of South Carolina Shawn Jenkins Children's Hospital
    Charleston, South Carolina 29425, United States
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06417385
Lead sponsor
Medical University of South Carolina
Responsible party
Haley Burdge (Medical/Dental Resident, Department of Pediatrics, Principal Investigator, Medical University of South Carolina) — Principal investigator
First posted
May 16, 2024
Start date
Feb 1, 2024
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Feb 6, 2026

Study contacts

Haley Burdge
Contact
burdge@musc.edu
8432144089
Dorothea Jenkins
Contact
jenkd@musc.edu
Haley Burdge
principal investigator · Medical University of South Carolina

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion